SCHEMBL874528

SCHEMBL874528

O=C(O)c1sc(-c2ccc([N+](=O)[O-])cc2)nc1O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.72
CDC7 O00311 3/20 0.60
DBF4 Q9UBU7 3/20 0.60
APP P05067 1/20 0.50
MMP2 P08253 1/20 0.50
MMP9 P14780 1/20 0.50
MMP8 P22894 1/20 0.50
MMP13 P45452 1/20 0.50
TDP1 Q9NUW8 1/20 0.49
CSNK2A2 P19784 2/20 0.47
CSNK2B P67870 2/20 0.47
CSNK2A1 P68400 2/20 0.47
TRPM8 Q7Z2W7 2/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 2/20 0.47
KMT2A Q03164 2/20 0.47
GAA P10253 2/20 0.47
KDM4E B2RXH2 2/20 0.47
MGAM O43451 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL874739 0.84 RAB9A (0.71) RAB9AAPPMMP2MMP9MMP8
SCHEMBL8867718 0.84 RAB9A (1.00) RAB9AAPPMMP2MMP9MMP8
SCHEMBL15048961 0.79 CDC7 (0.73) RAB9ACDC7DBF4TRPM8SMN1; SMN2
SCHEMBL9629491 0.79 RAB9A (0.59) RAB9AAPPMMP2MMP9MMP8
SCHEMBL15048913 0.78 RAB9A (0.73) RAB9ACDC7DBF4TRPM8SMN1; SMN2
SCHEMBL15049252 0.78 CDC7 (0.67) RAB9ACDC7DBF4TRPM8SMN1; SMN2
SCHEMBL15049359 0.78 RAB9A (0.69) RAB9ACDC7DBF4TRPM8SMN1; SMN2
SCHEMBL874463 0.78 RAB9A (0.65) RAB9ACDC7DBF4APPMMP2
SCHEMBL874800 0.78 RAB9A (0.62) RAB9ACDC7DBF4APPMMP2
SCHEMBL874100 0.77 RAB9A (0.64) RAB9AAPPMMP2MMP9MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012038904-A1 NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-03-29 WO disclosed